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Abstract
Disclosed herein is a PCR-based assay for Mycoplasma hyopneumoniae, a species-specific primer pair for use
in the assay, and a related diagnostic kit. The primer pair is made up of an oligonucleotide having the
nucleotide sequence 5'-AAGTTCATTCGCGCTAGCCC-3' and an oligonucleotide having the nucleotide
sequence 5'-GCTCCTACTCCATATTGCCC-3'. Preferably, the kit contains an oligonucleotide probe having
the sequence 5'-GGTAGCCCTTCCTTTGAGGT-3'.
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[57] ABSTRACT 
Disclosed herein is a PCR-based assay for Mycoplasma 
hyopneumoniae, a species-speci?c primer pair for use in the 
assay. and a related diagnostic kit. The primer pair is made 
up of an oligonucleotide having the nucleotide sequence 
5'-AAGTTCATI‘CGCGCI‘AGCCC-3' and an oligonucle 
otide having the nucleotide sequence 
5'-GCI‘CC'I‘ACI‘CCATATI‘GCCC-3'. Preferably. the kit 
contains an oligonucleotide probe having the sequence 
5'-GGTAGCCCITCCI‘ITGAGGT-3'. 
[56] 
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PCR-BASED ASSAY FOR M YCOPLASMA 
HY OPNE UMONIAE 
US GOVERNMENT RIGHTS 
The United States Government has certain rights in the 
invention described and claimed herein as a result of its 
support of cm'tain work related to the invention under grants 
from the United States Department of Agriculture USDA 
Grant 91-37204-6488 and the National Institute of Allergy 
and Infectious Diseases NIH Grant #K04AI01021. 
FIELD OF THE INVENTION 
This invention relates to diagnostic assays for the detec 
tion of microorganisms in a specimen and more particularly 
to a PCR-based assay for Mycoplasma hyopneumoniae, 
primers speci?c for the DNA of M. hyopneumom'ae, and 
diagnostic kits for detecting M. hyopneumoniae in a speci 
men. 
REFERENCES 
Several publications are referenced herein by Arabic 
numerals within parenthesis. Full citations for these refer 
ences may be found at the end of the speci?cation imme 
diately preceding the claims. The disclosures of these pub 
lications and any other publication referenced herein are 
hereby incorporated herein by reference in their entirety 
unless otherwise noted. 
BACKGROUND OF THE INVENTION 
Mycoplasma hyopneumoniae (Mhp) is the etiological 
agent of swine mycoplasma pneumonia. a chronic disease of 
high economical impact. The disease is characterized by low 
mortality but high morbidity. and its economic impact is due 
to growth retardation and a feeding ef?ciency reduction in 
infected swine (1). Despite a variety of approaches and 
repeated attempts. vaccines have not proven effective in 
preventing colonization or reducing disease in swine popu 
lations. Maintenance of cesarean-derived mycoplasma-free 
swine herds is marginally eifective because of the di?iculty 
in maintaining total isolation in swine (2). Eradication of this 
pathogen in chronically-infected animals through detection 
and elimination has not been possible because of difficulties 
in detection and maintenance of disease-free herds. The 
isolation of Mhp requires specialized media and extended 
incubation. and reproducible isolation from clinical samples 
requires strict adherence to media quality control. Serologi 
cal analysis is often used. but serological cross-reactions 
with M. hyorhinis or the nonpathogenic M. ?occulare com 
plicates analysis (3. 4) and is not generally accepted as a 
reliable diagnostic method. 
Alternative methods for detection of Mhp based on DNA 
DNA or DNA-RNA hybridization have been developed (5. 
6). These systems used either cloned fragments of DNA or 
synthetic oligonucleotides that exhibited species-speci?c 
reactivity. All of these probes suifer from low sensitivity and 
consequently have not gained wide acceptance in the diag 
nostic ?eld. Attempts to identify Mhp in nasal and lung 
washings from infected pigs have failed because of low 
sensitivity with non-radioactively labeled probes. Increased 
sensitivity can be obtained using l6S/23S rRNA-speci?c 
probes (6) because of the higher copy number of ribosomal 
sequences relative to a single copy chromosomal sequence. 
The polymerase chain reaction (PCR) has demonstrated 
enhanced sensitivity over ribosomal RNA probes (7). PCR 
detection has been applied to a number of important bacte 
rial pathogens. including mycoplasmas (8. 9). 
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None of these alternative methods have been shown to 
identify ?eld isolates of Mhp. We have developed a sensitive 
and speci?c PCR-based assay for ?eld isolates of Mhp. 
based upon a species-speci?c primer pair. This permits faster 
and better identi?cation of Mhp in swine, which will permit 
faster treatment and better control of the disease. 
SUMMARY OF THE INVENTION 
It is an object of the invention to provide PCR primers for 
use in a PCR-based assay for M. hyopneumoniae. 
Another object of the invention is to provide a diagnostic 
kit for use in detecting or measuring the presence of M. 
hyopneumoniae DNA in a sample. 
Afurther object of the invention is to provide a method for 
detecting or measuring the presence of M. hyopneumoniae 
in a sample. 
Additional objects and advantages of the invention will be 
set forth in part in the description that follows. and in part 
will be obvious from the description. or may be learned by 
the practice of the invention. The objects and advantages of 
the invention will be attained by means of the instrumen 
talities and combinations particularly pointed out in the 
appended claims. 
To achieve the objects and in accordance with the purpose 
of the invention. as embodied and broadly described herein. 
the present invention provides a species-speci?c polymerase 
chain reaction (PCR)-based diagnostic assay and reagents 
for the identi?cation of Mycoplasma hyopneumoniae (Mhp). 
The assay is based upon a primer pair for a target nucleic 
acid sequence in Mhp DNA that is believed to be species 
speci?c. In the method of the invention. the presence of Mhp 
in a sample is detected or measured by the steps of: (l) 
isolating the DNA from the Mhp in the sample; (2) ampli 
fying the quantity of the target nucleic acid sequence in the 
isolated DNA by PCR. using the primer pair of the inven 
tion; and (3) detecting or measuring the presence of the 
ampli?ed target nucleic acid sequence. 
The invention further includes a kit for use in detecting or 
measuring the presence of Mhp DNA in a sample suspected 
of containing such DNA. The kit comprises a container and 
the primer pair of the invention in such container. Preferably. 
the kit further comprises a probe that hybridizes to the target 
nucleic acid sequence ampli?ed by the use of the primer pair 
in the polymerase chain reaction. 
The accompanying drawings. which are incorporated in 
and constitute a part of this speci?cation, illustrate one 
embodiment of the invention and. together with the 
description. serve to explain the principles of the invention. 
BRIEF DESCRIPTION OF THE DRAWINGS 
FIG. 1 shows a comparison of Mhp and M. ?occulare 
reactivity to PCR primer pairs MHPl/2 and MHP3/4. DNA 
of Mhp (1 ng) and M. ?occulane (100 ng) were subjected to 
PCR ampli?cation as described in the Materials and Meth 
ods. One tenth of the reaction mixtures were examined by 
ethidium bromide -~agarose gel electrophoresis (2% 
agarose). Lanes 1-6 contain reactions with the PCR primer 
pair MHP1/2 and lanes 8-14 with the PCR primer pair 
MHP3I4. The following DNAs were ampli?ed: lanes 1 and 
9. Mhp I; lanes 2 and 10. Mhp 232; lanes 3 and 11. M. 
?occulam 10019; lanes 4 and 12. M. ?occulare 10020; lanes 
5 and 13. M. ?occulare 18057; lanes 6 and 14. M. ?occulare 
2739; lane 7. kb ladder size standard; lane 8. PCR reaction 
with no DNA added. 
FIG. 2 shows the results of PCR ampli?cation of Mhp 
?eld isolate DNAs with the MHP3/4 PCR primer pair. PCR 
5.712.090 
3 
products from reactions with the same DNAs with annealing 
temperatures of 58° C. (upper panel) and 56° C. (lower 
panel) are shown. 
FIG. 3 shows a determination of PCR sensitivity of 
ampli?cation of Mhp strain 1 DNA with the MHP3/4 primer 
pair. Each reaction was performed as described in Example 
1 with 30 cycles of ampli?cation. The amount of DNA added 
to each reaction mixture shown in lanes 1-6 is 10 ng. 1 ng. 
0.1 ng. 0.01 ng. 0.001 ng. and 0.0001 ng respectively. Lane 
7 contained no DNA and lane 8. kb ladder size standards. 
FIG. 4 shows the DNA sequence of a 2.3 kb fragment of 
M. hyopneumoniae chromosomal DNA. 
DETAILED DESCRIPTION OF THE 
lNVENTION 
Reference will now be made in detail to the presently 
preferred embodiments of the invention. which. together 
with the following example. serve to explain the principles 
of the invention. 
The invention relates to a PCR-based assay that is speci?c 
for M. hyopneumoniae (Mhp). It is based upon a pair of 
species-speci?c primers that are used in the assay. The 
primers. in turn. are based upon a target nucleic acid 
sequence that is speci?c for Mhp. As used herein. the term 
"target nucleic acid sequence” is a portion or segment of 
Mhp chromosomal DNA represented by a speci?c sequence 
of speci?c nucleotides. The quantity of this part of the DNA 
will be ampli?ed by the polymerase chain reaction. 
The primer pair comprises an oligonucleotide having the 
nucleotide sequence 5'-AAGTI‘CA'ITCGCGCI‘AGCCC—3' 
(SEQ ID NO: 1) and an oligonucleotide having the nucle 
otide sequence 5‘-GCI‘CCTACI'CCA'I‘ATTGCCC-3' (SEQ 
ID NO: 2). The primers have a higher GC than AT content. 
having a GC content of approximately 55%. This permits 
them to be used at a higher annealing temperature. This 
limits the problem of false priming and provides for a more 
speci?c reaction. 
The primers are used in a PCR-based assay for detecting 
the presence of Mhp in a sample. The DNA from the Mhp 
in the sample is isolated by standard techniques. The quan 
tity of the target nucleic acid sequence in the isolated DNA 
that is species-speci?c for Mhp is then ampli?ed by PCR. 
using the primer pair of the invention. The presence of the 
ampli?ed quantity of the target nucleic acid sequence in this 
second sample is then detected by standard techniques. 
The target nucleic acid sequence was determined by 
analysis of the 2.3 kb Mhp chromosomal DNA fragment 
identi?ed in Example 1. the sequence SEQ ID N024 of 
which is shown in FIG. 4. Standard computer algorithms. 
based upon the estimated melting temperature. potential 
secondary structure. and other factors known to those skilled 
in the art. were applied to the sequence shown in FIG. 4 to 
identify primer candidates. from which the primers of the 
invention were selected. (See Rychilk and Rhoads. “A 
Computer Program for Choosing Optimal Oligonucleotides 
for Filter Hybridization. Sequencing. and In Vitro Ampli? 
cation of DNA." Nucleic Acids Research, 17:8543-8551 
(1989). incorporated herein by reference.) The MHP 3/4 
primer pair binds to the sequence as shown in the figure. 
thereby identifying a target nucleic acid sequence compris 
ing nucleotides 810 to 1264 of the sequence shown in FIG. 
4. 
The DNA is isolated from the microorganism by standard 
techniques. Basically. the cell walls are disrupted. and the 
DNA is extracted. Preferably. the DNA is precipitated and 
resuspended in buffer. 
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The target nucleic acid sequence in the extracted DNA is 
ampli?ed by the use of the polymerase chain reaction in 
conjunction with the teachings contained herein. The PCR 
technique is well known. See U.S. Pat. No. 4.683.195. 
issued Jul. 28. 1987 to Mullis et al.. U.S. Pat. No. 4.683 .202. 
issued Jul. 28. 1987 to Mullis. U.S. Pat. No. 4.800.159 
issued Jan. 24. 1989 to Mullis et al.. U.S. Pat. No. 4.965.188. 
issued Oct. 23. 1990 toMullis et al.. U.S. Pat. No. 4.889.818. 
issued Dec. 26. 1989. to Gelfand et al.. and U.S. Pat. No. 
4.902.624. issued Feb. 20. 1990. to Columbus et al.. all of 
which are incorporated herein by reference. See also Bej et 
al.. “Ampli?cation of Nucleic Acids by Polymerase Chain 
Reaction (PCR) and Other Methods and Their 
Applications." Critical Reviews in Biochemistry and 
Molecular Biology, 26(3/4):301—334(1991). which is also 
incorporated herein by reference. 
In general. the polymerase chain reaction involves the use 
of a pair of speci?c oligonucleotide primers to initiate DNA 
synthesis on a target DNA template. Two oligonucleotide 
primers are used for each double-stranded sequence to be 
ampli?ed. The target sequence is denatured into its compli 
mentary strands. Each of the primers. which are su?iciently 
complementary to a portion of each strand of the target 
sequence to hybridize with it. anneals to one of the strands. 
The primers are extended. using nucleosides in the sample 
and a polymerization agent. such as heat-stable Taq DNA 
polymerase. This results in the formation of complementary 
primer extension products. which are hybridized to the 
complementary strands of the target sequence. The primer 
extension products are then separated from the template 
strands. and the process is repeated until the desired level of 
ampli?cation is obtained. In subsequent cycles. the primer 
extension products serve as new templates for synthesizing 
the desired nucleic acid sequence. 
More speci?cally. the sample containing the isolated Mhp 
DNA is heated in the presence of the four different nucleo 
side triphosphates and the primer pair for an eifective time 
and at an effective temperature to denature the DNA in the 
sample. Each oligonucleotide primer is su?iciently comple 
mentary to different strands of the target nucleic acid 
sequence to hyridize with them. such that an extension 
product is synthesized from each oligonucleotide primer. 
When separated from its complement. the extension product 
serves as a template for the synthesis of the extension 
product of the other oligonucleotide primer. Preferably. the 
temperature is in the range 85° C. to 95° C. and most 
preferably is at about 92° C. The time is from 0.5 minute~4 
minutes and preferably about two minutes. Preferably. the 
nucleoside triphosphates are deoxyribonucleoside triphos 
phates. 
The denatured DNA is then cooled to a temperature that 
promotes hybridization, i.e.. annealing. of each oligonucle 
otide primer to its complementary strand. Preferably. this 
temperature is from 54° C. to 58° C. and most preferably 
about 56° C. 
The natured DNA is contacted with a thermostable 
enzyme that catalyzes the combination of the nucleoside 
triphosphates to form primer extension products comple 
mentary to each strand of DNA. The thermostable enzyme 
is preferably a polymerase from Thermus aquaticus. Most 
preferably the polymerase is Taq polymerase. The thermo 
stable enzyme can be added after the denaturing or anneal 
ing steps or at the same time. 
This mixture is maintained at an effective temperature and 
for an effective time to promote the activity of the enzyme 
and to synthesize. for the target nucleic acid sequence being 
5,712,090 
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detected. an extension product of each oligonucleotide 
primer that is complementary to each strand of the sequence. 
The temperature must not be so high as to separate each 
extension product from its complementary strand at this 
point. The temperature can range from 55°—85° C. and most 
preferably is about 72° C. The time is 0.5-4 minutes. 
preferably about 1 minute. 
These steps are then repeated with the primer extension 
products. The annealed DNA is denatured by heating the 
mixture from the previous step for an effective time and at 
an effective temperature to separate the primer extension 
products from the strands on which they were synthesized to 
produce single stranded molecules. However. the tempera 
ture must not be so high as to denature the enzyme irrevers 
ibly. Preferably, the temperature is from 85° C. to 95° C. and 
most preferably about 92° C. The time is from 0.5 minute to 
4 minutes and most preferably about 1 minute. 
This mixture is then cooled for an effective time and to an 
etfective temperature to promote hybridization (annealing) 
of each oligonucleotide primer to its complementary single 
stranded molecule produced by the prior step, and the 
mixture is maintained at an effective temperature and for an 
effective time to promote the activity of the enzyme and to 
synthesize an extension product of each oligonucleotide 
primer that is complementary to each strand of the target 
nucleic acid sequence being detected. Preferably. the tem 
perature is from 85° C. to 95° C. and preferably about 92° 
C. Preferably, the time is from 0.5 minute to 4 minutes and 
most preferably about 1 minute. This results in the ampli 
?cation in the quantity of the target nucleic acid sequence. 
if it is present. This step of primer extension and the prior 
step of annealing may be carried out simultaneously or 
sequencially. 
The cycle of denaturing. annealing. and primer extension 
is carried out at least 20 times. preferably 30 times. 
The ampli?ed DNA is detected by standard techniques in 
conjunction with the teachings contained herein. For 
example. it can be detected by a probe or by the use of gel 
electrophoresis. 
When a probe is used. the ampli?ed DNA is rendered 
single stranded. The probe is brought into contact with a 
mixture containing the denatured ampli?ed target nucleic 
acid sequence. A determination is made whether or not 
hybridization has occurred. Preferably. the probe is an 
oligonucleotide that has been labeled with a detectible entity. 
The probes can be prepared by standard techniques 
known to those skilled in the art. given the target sequence 
of the invention and the teachings contained herein. 
Preferably. the probe is an oligonucleotide with about 17 to 
about 27 nucleotides that hybridizes to the target sequence. 
More preferably. it is about 21 to 27 nucleotides in length. 
Preferably. the GC is content is at least 50% and most 
preferably 55%. The preferred probe of the invention is 
5'-GGTAGCCCTTCCITI‘GAGGT-3‘ (SEQ ID NO: 3). 
A detectable entity is attached to the oligonucleotide. 
Such detectable entity is a detectable molecule or 
compound. such as a radioactive isotype or biotin. 
Alternatively. the PCR product can be detected by elec 
trophoresing it on a gel. which separates the DNA by 
molecular weight. The ampli?ed DNA will appear as a 
single band at a certain size with reference to molecular 
weight standards. The band is visualized by standard 
techniques. such as staining with ethidium bromide followed 
by illumination with ultraviolet light. 
The invention also includes a ldt for use in detecting the 
presence of Mhp DNA in a sample suspected of containing 
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it by detecting the target nucleic acid sequence within the 
DNA. The kit comprises a container and the primer pair of 
the invention within the container. Preferably. it also con 
tains a probe that hybridizes to the target nucleic acid 
sequence ampli?ed by the use of the primer pair of the 
invention in the polymerase chain reaction. Most preferably. 
the kit further contains a nucleic acid polymerase. preferably 
Taq. and additional means. such as reagents. for detecting 
the hybridization of the probe to the ampli?ed DNA. 
It is to be understood that the application of the teachings 
of the present invention to a speci?c problem or environ 
ment will be Within the capabilities with one having ordinary 
skill in the art in light of the teachings contained herein. 
Examples of the products and processes of the present 
invention appear in the following example. 
EXAMPLE 1 
Development of Polymerase Chain Reaction 
Primers to Detect Mycoplasma hyopneumom'ae 
The purpose of this study was to develop a species 
speci?c polymerase chain reaction (PCR)-based diagnostic 
reagent for the identi?cation of Mhp. Based upon DNA 
sequence analysis of a cloned fragment of Mhp DNA. two 
pairs of PCR primers were constructed and tested against 
different strains of Mhp. Mycoplasma ?occulare, other 
mycoplasma species. and non-Mollicute microorganisms 
which commonly inhabit the respiratory tracts of swine. A 
total of 4-0 ?eld isolates of Mhp and 6 ?eld isolates of M. 
?occulare have been examined. One pair of primers, MHP 1/ 
2. gave a nonspeci?c reaction with M. ?occulare, Myco 
plasma hyorhinis, and Mycoplasma hyosynoviae. The sec 
ond primer pair. MHP3/4. gave a positive signal in PCR with 
Mhp reference strains and all 40 Mhp ?eld isolates. but not 
with other Mollicutes or microorganisms. Examination of 
the protein patterns of the non-reactive strains by SDS 
PAGE indicated a signi?cant protein variation in these 
isolates as compared to the reference strains and PCR 
positive isolates. These results indicate that Mhp is geneti 
cally heterologous and displays signi?cant protein variabil 
ity. 
MATERIALS AND METHODS 
Organisms and culture conditions 
The mycoplasma and other bacterial strains used in this 
study as the source of chromosomal DNA for positive and 
negative samples in the PCR reactions are listed in Table 1. 
All mycoplasmas were grown and maintained in Friis 
medium supplemented with 20% horse serum and fresh 
yeast extract (10). Field isolates of Mhp representing 40 
isolates from different sources were obtained from Dr. R. F. 
Ross at the Veterinary Medical Research Institute. Iowa 
State University. All strains were stocked at —70 C. All ?eld 
isolates were typed using ?uorescence antibody (11) and/or 
metabolic inhibition (12). and in some instances. protein 
pro?les were compared using sodium dodecyl sulfate poly 
acrylamide gel electrophoresis (13). 
Construction and screening of the Mhp genomic DNA 
library 
A Mhp gene library in pUC19 was prepared as follows. 
DNA was prepared according to known methods (14). The 
purity and concentration was determined spectrophotomet 
ricaly. The ratios of optical densities at 260 and 280 were 
more than l.8—2.0. Plasmid DNA was obtained as previ 
ously described (15). DNA of M. hyopneumoniae strain J 
was digested by EcoRl. Fragments of 1-4 kb were separated 
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on agarose gel and ligated into EcoRl sites of plasmid 
pUCl9. which was used for transformation of E. coli JM109 
(16). Clones of recombinants of white color were checked 
by in situ hybridization with DNAs of M. hyopneumoniae 
and M. ?occulure. The selected clones were used for DNA 
preparation. and they were analyzed by dot-blot and South 
ern blot hybridization (17). DNAs of mycoplasmas and 
plasmids were labeled by 32F by nick translation (18). The 
hybridization was performed for 12 hours at 60° C. in a 
mixture of 2><SSC. 0.2% SDS. 5><Denhardt solution. and 100 
mg/rnl DNA of salmon sperm. Filters were washed after 
hybridization with 2><SSC containing 0.2% SDS at room 
temperature and with 0.2><SSC containing 0.2% SDS at 60° 
C. The insert of the ?nal speci?c plasmid recombinant was 
analyzed by EcoRl. NdeI. and Dral. 
Two hundred and eighty-two clones of recombinant plas 
mids were examined. At ?rst. 28 clones giving strong 
hybridization only with DNA of M. hyopneumoniae were 
selected. Dot-blot hybridization of the recombinant plasmids 
of the selected clones with 321’ labeled DNAs of M. 
hyopneumoniae, M. hyorhinis, M. hyosynoviae, A. 
granular-um, and A. Iaidlawii was done. Based on a com 
parison of the hybridizations. we selected for further study 
plasmids A8. B3. C4. C9. and D7. which were renamed 
pMhpOl. pMhpOZ. pMhp03. pMhp04. pMhpOS. and 
pMhp06. They contained inserts of M. hyopneumoniae of 
l-4.5 kb. Southern-blot hybridization of these plasmids with 
DNAs of M. hyopneumoniae, M. ?occulure, M. hyorhinis, 
and M. hyosynoviae labeled with 32P was done. Filters 
exposed 15 hours after hybridization showed positive reac 
tion of all inserts with only DNA of M. hyopneumoniae. 
After a 72 hour exposure of the ?lters. a slight hybridization 
signal was observed between DNA of M. ?occubre and 
plasmids pMhpOl. pMhpOZ. pMhp03. and pMhp06 and 
between DNA of M. hyorhinis and pMhp03 and pMhp04 as 
well as between M. hyasynoviae and plasmid pMhpOl. 
Based on these results. pMhpOS was selected as potential 
source for a gene probe for the identi?cation of M. hyop 
neumoniae. This plasmid harbored a 2.3 kb insert of Mhp 
chromosomal DNA. 
Further hybridization testing with pMhpOS failed to dem 
onstrate reactivity to M. gallisepticum, M. arginini, M. 
.rynoviae, M. ?occulare, and A. axanthum chromosomal 
DNAs. Also there was no reaction to the DNA obtained from 
the spleen and lung of gnotobiotic piglets or to DNAs from 
other bacterial swine pathogens including Escherichia coli, 
Salmonella gallinarum, Staphylococcus aureus, Bordetella 
bronchiseptica, Erysipelothrix rhusiophiae, Haemophilus 
parasuis, Corynebactcrium pyogenes, and Pasteurella mul 
tocida. 
DNA sequencing and PCR primer selection 
The DNA sequence of the 2.3 kb fragment of Mhp 
chromosomal DNA in plasmid MhpOS was obtained using 
standard dideoxy sequencing techniques (19). A series of 
deletion mutants was constructed by the method of Heniko?‘ 
(20) described by Maniatis et al. (15) to aid in the sequenc 
ing. Alignment of overlapping sequences was performed 
using the DNASIS software program (Hitachi Software 
Engineering America. Ltd. San Diego. Calif). Four 20 base 
pair nucleotide sequences were chosen as potential PCR 
primers using the DNASIS and OLIGO (Northern 
Biosciences. Minneapolis. Minn.) software programs. The 
primer sequences used in this study were as follows: MHPl 
(5'-TGTGTAGI'I‘GGCCAATCI‘GG-3') SEQ ID NO:5', 
MHP2 (5’-GAl'I‘I‘CCGGTI‘GG'ITCAI‘CG-3') SEQ ID 
NO:6; MHP3 (5'-AAG'I'TCATI‘CGCGCTAGCCC-3') SEQ 
ID NO:1; and MHP4 (5'-GCI‘CCTACI‘CCA'I‘ATTGCCC 
3') SEQ ID NO:2. 
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Preparation of samples for PCR 
DNA from mycoplasma cultures was isolated by a modi 
?cation of the method of Marmur as described by Maniatis 
et al. (15). Brie?y. 100 pl of 30 mM Tris-HCl—30 mM 
EDTA-300 pg/ml Proteinase K (pH 8.0) was added to 200 
p1 of an overnight culture. The preparation was inmlbated at 
50° C. for one hour and extracted once with phenol! 
chloroform (1:1) and once with chloroform. The DNA was 
coprecipitated with yeast tRNA by adding two volumes of 
ethanol. and the pellet was dissolved in 20 pl of TE bu?‘er 
(10 mM Tris-HCl-—0.05 mM EDTA. pH 8.0). DNA con 
centrations were determined by ?uorescence using the Bio 
Rad model TKO 100 Mini-Fluorimeter (Bio-Rad 
Laboratories. Richmond. Calif). 
DNA ampli?cation by PCR 
Oligonucleotides were synthesized by standard methods 
using an automated DNA synthesizer (Applied Biosystems 
DNA synthesizer. Foster City. Calif). PCR reactions were 
performed in a ?nal volume of 50 pl containing 50 mM KCl. 
10 mM Tris-HCl (pH 9.0), 01% Triton X-100. 4 mM MgCl. 
0.11 pM primers. 40 pM of each deoxynucleoside 
triphosphates. and 0.5 unit of Tag DNA Polymerase (Gibco 
BRL. Gaithersburg. Md.). An overlay of mineral oil was 
added to each tube followed by denaturation at 92° C. for 2 
min. Cycling parameters that gave the best results were 92° 
C. for 1 min.. 56° C. for 1 min.. 72° C. for l min for 30 
cycles. The ?nal cycle included a 3 minute primer extension 
step at 72° C. to completely extend all ampli?cation prod 
ucts. Following ampli?cation. mineral oil was removed from 
aqueous PCR reagent mixtures. 5 to 10 pl of the reaction 
mixture was electrophoresed in a 2% agarose gel. and the 
PCR products were visualized by ethidium bromide staining 
and UV illumination. 
RESULTS 
A genomic library of Mhp chromosomal DNA was con 
structed in plasmid pUCl9 and screened for species-speci?c 
fragments. One 2.3 lrb fragment was selected for further 
study based upon its lack of hybridization with other swine 
commensal and pathogenic bacteria. A total of 6 Mhp ?eld 
isolates were tested in DNA-DNA hybridization reactions in 
this earlier study. and all reacted positively. 
Two primer pairs were selected using the OLIGO and 
DNASIS software programs. The two primer pairs. MHPl/Z 
and MHP3/4. had a 50% and 55% GC mol % content, 
respectively. The speci?city of the primer pairs was evalu 
ated using chromosomal DNA from diiferent mycoplasma 
species and strains in PCR reactions. The MHPl/2 primer 
pair gave a positive signal not only with the DNA from Mhp. 
but also with the DNA of M. ?occulare (FIG. 1). M. 
hyorhinis and M. hyosynoviae (data not shown). With DNA 
from Mhp and M. ?occulane, a 390 bp band was observed 
with the MHPl/Z primer pair (FIG. 1). The second primer 
pair (MHP3/4) gave positive results with DNA from Mhp. 
but not with DNA from M. ?occulare (FIG. 1). Primer pair 
MHP3/4 failed to produce a reaction product using DNA 
from other mycoplasmas. bacteria or swine tissues (data not 
shown). 
Atotal of 40 ?eld strains were examined by PCR using the 
MHP3/4 primer pair. See Table 1. Each of these isolates 
reacted positively with the MHP3/4 primer. but in prelimi 
nary studies when annealing temperatures were at 58° C.. a 
weak band was observed in 22 of the 40 ?eld isolates (FIG. 
2). This was in contrast to the type strains 232A and J. which 
consistently gave a strong band with the MHP3/4 primer 
pair. To determine the optimum reaction conditions for all 
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Mhp strains. PCR reactions were performed at di?erent 
annealing temperatures (54°—58° C.) and diiferent magne 
sium concentrations (0-10 mM) with the Mhp J strain as 
well as several variant ?eld isolates. With the MHPl/Z 
primer pair. the optimal magnesium concentration was 2 
mM. and with the MHP3/4 primer pair. the optimal concen 
tration was 4 mM. There was no di?'erenoe in the PCR 
reaction using the MHP 3/4 primer pair with the J strain 
when the annealing temperature was varied from 54°—5 8° C. 
(data not shown). The variant ?eld isolates. however. gave 
a much stronger band when the annealing temperature was 
lowered 2° C. to 56° C. (FIG. 2). The protein patterns of ?eld 
isolates that reacted strongly with the MHP 3/4 primer pair 
at 58° C. was compared to several that reacted weakly by 
SDS-PAGE. From a limited analysis. the ?eld strains could 
be divided into two distinct patterns (data not shown). At all 
annealing temperatures used. DNAs from other mycoplasma 
species failed to react (data not shown). Variability in the 
quantity of ampli?ed fragments was observed with DNA 
from some ?eld isolates (FIG. 2). This was assumed to be 
due to either the quantity or quality of the template DNA. 
However. di?’erences in the ampli?ed sequences of some of 
the ?eld isolates could not be ruled out. 
The sensitivity of the MHP3/4 PCR primer pair was 
determined by varying the quantity of template DNA in the 
PCR reaction as shown in FIG. 3. Positive products could be 
observed at DNA concentrations as low as 1 picogram of 
DNA. 
DISCUSSION AND CONCLUSIONS 
Enzootic pneumonia is one of the more important diseases 
in swine populations. resulting in signi?cant economic 
losses worldwide. Since there are no effective vaccines 
against the causative organism. Mhp. control of the disease 
depends upon accurate diagnosis and eliminan'on of infected 
swine. Diagnosis of Mhp infection is presently based on 
isolation and characterization of cultures from clinical 
samples. and the attendant pathomorphological and sero 
logical investigations. All of these methods are di?iculL 
insensitive. time consuming and are often not su?iciently 
reliable. To overcome these problems. signi?cant effort has 
been made in the development of new diagnostic reagents 
and tests. Included are more rapid and sensitive enzyme 
linked immunosorbent assays (21). DNA-DNA hybridiza 
tion probes (6). and PCR (8). 
The most promising technology is PCR. which has been 
shown capable of detecting as few as 4 organisms in clinical 
samples (22). It is also an exquisitely speci?c technique. but 
problems can still arise because of genomic diversity in 
environmental samples. Our results support this idea. since 
the 40 Mhp ?eld isolates could be separated into two distinct 
groups based upon their PCR patterns at two different 
annealing temperatures. The DNA sequence variability 
responsible for this diversity is not known. 
The MHP 3/4 primer pair described in this example 
produces a 474 base pair fragment with all Mhp isolates 
tested. but failed to react with other mycoplasma or bacterial 
DNAs. The sensitivity demonstrated with primer pair 
MHP3I4 was approximately 1 pg after 30 cycles of ampli 
?cation (FIG. 3). Based on previous studies of detection of 
mycoplasmas in clinical samples (22). this level of sensi 
tivity should be adequate for the identi?cation of Mhp in 
swine respiratory tissues and possibly in tracheal swabs. 
Increased sensitivity could be achieved either by increasing 
the number of PCR cycles. the use of radioactivity. a second 
round of ampli?cation with a pair of inner primers, or other 
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signal enhancing techniques (7. 23). For example. in one 
experiment. 5 additional cycles of ampli?cation resulted in 
a 10-fold increase in sensitivity (data not shown). 
TABLE 1 
STRAINS AND PCR RESULTS 
Strain Scmroe Ml-lPl/Z MI-[P3l4 
M. Hyvpneumoniae 
1361A IVDL+ ++ ++ 
1375C IVDL ++ ++ 
1417 IVDL ++ H 
1419 IVDL ++ + 
1424B IVDL ++ ++ 
1472C IVDL ++ + 
1363 IVDL ++ + 
1375A IVDL ++ ++ 
1378A IVDL H- -H 
1381A IVDL -H- -H 
1416B IVDL +—t- + 
1464A IVDL -H- + 
8489 IVDL + Chen ++ + 
8765 IVDL + Chen ++ ++ 
9078 IVDL + Chen ++ + 
9275 IVDL + Chen H- + 
10731 IVDL + Chen ++ + 
10986 IVDL + Chen ++ + 
11684C IVDL + Chen ++ + 
8689 IVDL + Chen ++ ++ 
10954 IVDL + Chen 4+ + 
11928 IVDL + Chen 4+ + 
P + 18145 Armstrong 4+ 4+ 
P + 1814 + 10 Armstrong -H- + 
P + 5398 + 1 Armstrong -|+ + 
P + 57 82 Armstrong 4+ + 
P + 6053 + 2 Armstrong ++ ++ 
P + 6053 + 3 Annstrong ++ + 
P + 6053 + 4 Armstrong ++ + 
P + 11318 + 6 Armstrong ++ + 
P + 12895 + 2 Armstrong 4+ + 
P + 13129 + 6 Armstrong 1+ 4+ 
P + 13129 + 9 Armstrong ++ ++ 
31 + 9 PIC + BE ++ ++ 
37 + 9 PIC + BE 4+ 4+ 
3 + 14 PIC + BE -++ ++ 
4 + 14 PIC + BZE ++ ++ 
16 + 14 PIC + BZE 4+ 4+ 
18 + 14 PIC + BZE ++ ++ 
232A Ross 4+ H 
J Ross ++ -H 
M. ?ooculare 
10019 Stipkovits ++ - 
10020 Stipkovits ++ — 
18057 Stipkovits ++ — 
27 39 Stipkovits ++ — 
M542 Stipkovits ++ — 
M. gallirepticwn Minion — — 
M. hyusynoviae Stipkovits -H- — 
25591 ATCC ~H- — 
M. hyurhinis Stipkovits -H- — 
GDL Ross +1- — 
M. pulmonis Minion — — 
A. laidlawii Minion — — 
A. gmlwlarum Stipkovits — — 
A. axanrhum Stipkovits — — 
Escherichia coli Stipkovits — - 
Salmonella Stipkovits — — 
gallium-um 
Staphylococcus Stipkovits — 
aurzus 
Bordetzla Stipkovits — — 
bronchi-septic 
Ersipelathrix Stipkovits — — 
rhusiophiae 
Haemophilus Stipkovits — — 
paras-m‘: 
Corynebacae?um Stipkovits — - 
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TABLE l-oontinued 
STRAINS AND PCR RESULTS 
Strain Source MHP1/2 MHPSM 
pyugener 
Paneurella Stipkovits — — 
mulmcida 
Myoobacterium Stipkovits - — 
bovis 
Chlamydia Stipkovits — — 
nuchomatis 
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sequence us'nno 
(1)6ENE‘IALINFORMATION: 
(iii )NUMBEIOFSBQUENCESzG 
( 2 ) INFORMATION FOR SEQID N'Ozl: 
(i)SBQUENCECi-IARACIEZISTKS: 
(A )LENG'I'HzZObmpuirs 
(B)TYPE:nuc1eiaacid (C)STR.ANDB)NESS:|ing1e 
13 
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(1) )TOPOLOGY: 1mm 
( i i )momcum'rmmmmm) 
( x i )SBQUENCE DESCRIPTION: SEQ ID NO:1: 
AAGTTCATTC GCGCTAGCCC 
( 2 )INFORMAI'IONFORSEQIDNOz2: 
( i )SBQUENCECHARACTERISTICS: 
(A)LENGTH:20bampairs 
(B )TYPEzmwleicacid 
(c )S'IRANDEDNESS:singk 
(D)TOPOLOGY:EM 
( i i ) MOLECULE TYPE: DNA (genomic) 
( x i )SBQU'ENCEDESCRIPTIONzSEQEDNOzZ: 
GCTCCTACTC CATATTGCCC 
( 2 )INFORMKI'ION FOR SEQ ID NO:3: 
(C )S'IRANDEDNFSS:sing1c 
(D)'IOPOLOOY:1imar 
( i i )MOLECULE TYPE: DNA (gemmic) 
( x i )SEQUENCEDESCRIP'I'ION2SBQIDNOS: 
GGTAGCCCTT CCTTTGAGGT 
( 2 )INNRMATIONFORSEQIDNOA: 
( i )SEQUEVCECHARACI‘EIISTICS: 
(A)LENGTH:Z§34\m-wepain 
(B)TYPE:mcldcacid 
(C )STRANDEDNESSzsingle 
( D )TOPOLOGY: l'mcm' 
( i i )Mowwua TYPE: DNA (genomic) 
(x i )SBQUENCEDESCRIP'HON:SEQDNO:4: 
GGAATTCCAG CCAATCTTTT AATTAAAATT 
TTTCGCTGAG 
AACATTGAGT 
ATTAAAACAC 
TTTAGAAATT 
ATATTTTATC 
GAGGCAAACA 
GTGACCTTTT 
CTTCTTTCCT 
GTAAAATTTA 
ATGCAAAATC 
TTATGTACAA 
GGGTTTTATT 
TCCTCTGCTC 
GATGATAAAT 
OTTTTTTGAC 
TTCCTTCGAC 
AAGTAAAAAT 
TGTTACTTAA 
ATAAAAAAAC 
TACTAATTAA 
ATTCTGATAT 
TATTTTTACT 
AGTTAAAACC 
TAAAAAAOAA 
TTCTTACAAC 
CGGGGACAGA 
TGOACCCATT 
ATTTAAAAAT 
ATTGTTAATA 
ATTTATTAAT 
AAAAATAACA 
GTTTTTAGAT 
AATTTTAATT 
TATAAAATTC 
TTGCAAATAA 
TTTTTTTTTT 
CAACAAACCT 
TCTAAAAAAA 
AACCACAACA 
AAATATTAAA 
TAAATCGTTA 
TGAACAAGAT 
TTATCTTTAT 
AAAATTTGTT 
TGGTAGACAA 
CCAATAATTA 
TTTAACATAO 
TTTGATTTTA 
TATAOTAAAA 
TTCAATATTA 
TTTTTTTTTT 
AACTTATAAA 
ATATCCTTAT 
ACAATTTCTA 
AATGCAAGTT 
AGTTCATTCG 
AATTACGCAG 
ATTTGAAAAC 
GGCCATTTTT 
AGATAAAAAG 
AGCGATTTTT 
TTATTAAATC 
TAATAAAAAG 
TAATTTGATT 
TTCAATGTTT 
TTTGTTAAAA 
ACCGAAAGGA 
TTTTCGGAAT 
TTAGAAATGA 
CAATAGCTTC 
CGCTAGCCCA 
GGGAAATCTC 
TACCACATCA 
TAAGGTTGGA 
CGCAGAAACT 
CTTAATAAAT 
TATTTCTTTG 
TGCTGAATTT 
TAGTAAAGAA 
TATAAATATT 
TTATTGCATA 
ATTAGTAATA 
TTTTGGTTCT 
AAATGCAAAC 
TACAATTTTT 
AAAATATGTA 
GCTTCTCGGA 
2 0 
20 
2 0 
240 
3 00 
36 D 
420 
4 80 
600 
660 
7 2 0 
7 DD 
840 
9 00 
5,712,090 
15 16 
-continued 
GCAAAATCCA TAGTTTATTT TGGTGGATTA TTTTGGGAAG ATAAAGTTGC ATGAGCAAGT 9 60 
AATTTAACAG TAAAACATCA AAAAAAAOTA AGTCCATATT ATATAACAAG TAAGCCAAAA 10 20 
TATATTGAAG CAACCTTAAA AACTTGAACC TCGGGC'ITAG GTAOCCCTTC CTTTGAGGTA 10 80 
GGCGGGGAAA TAAAATATAA TGGTAATTTC AGATCTAATT TAGGTATAAA AATTGGAATA 1 140 
GATTATGGAA CTAGAOAATT ATTTATTACT AAAAGTGTTC AAAACCTACC ACAAGCTAAA l 2 OD 
ATAACTTATG CGGGTACGGG TTGGAGATAC AAAGTAACTT CATATGGGCA ATATGGAGTA 1 2 60 
GGAGCAATAG AAACTGAAGA TGAATTTTTA ATGTTTAATA CTGAAAATTC AATGATTACA l 3 20 
ACACGACGAA AAAGAAAACC TAAAACATCA TTTCCTGATA TTTTAGGTCG TTATATCGAA 1 3 8O 
GAAAAATACG GGCATTTACC TGAAGAAGAT GATAATAATT AATAACTTAA GTAAAAAGTT 1 440 
TGAAACTAAA TCGATTTTTG AAAAAATTAA TTTAOAAATT CCCACAAACA AACTAACTTT 15 O0 
TGTAGTTGGC GAATCTGGGA TGGGAAAATC AACCTTAATT AATTTAATTG CCGGTTTTAC 15 60 
TAAAAAAGAT GAAGGTGAAA TTATCTTTTT TAAAGATGOA AAAGAAGAAA AAAATCCTTT 1 620 
AATTGATGTA GTTTTTCAGG ATTTTAACCT AATTGAAAAT CTTTCTGTTA AAAATAATAT l 6 BO 
TTTAATTGGA AATAGCTTAA TTCAAAAAGA ATTTGATCAA AATTTGCTTO AAAAAAGAGC l 7 40 
AAATTTTCTT AATATTGAAA ATGAAAAACT AAATCAACAA GTCAAAGATT TATCGGGTGG 1 B00 
CGAGAAACAA AGAGTCGGTA TTTTACGTGC TTTTTCGCOA AATTCAGATT TTATTTTACT 1 860 
CGATGAACCA ACCGGAAATC TTGATGAGGA AAATGCAGTT GCTGTTTTTG AAAATTTAAA 1 9 20 
AAAATTATCA AAAAACAAAA CTATTTTGGT TGTTAGTCAC AATTTAOAAC TAGCAAAAAA 1 9 80 
ATATGCAGAT CAAATTATCC ATATCAAAAA AGATACTATT GATGTTGAAA CTTTTGACAA 2 0 40 
AAAGAAAAAA ACACAAGAAA ATGAGAGTGA AAATTCTGCT TTTGTTTCAT AAATTGAACA 2 l 0 0 
AAAACCAGTT TTTAAT'I'TTT TAACGAAATA TAAAACTGGT TTTTTGCTAG CTTTTGCCGA 2 1 6O 
TTTTAAAACA AAAATAACAA CTTTTATTTT ATTAATTATT GTTTTTTTTG TTTTTATAAG 2 2 20 
TGGGGGCACA TTGTTCACTT CACTACAGAT TTCTGCAAAA AATCTCAATT TGTCTAAGGT 22 80 
CCAGGAATAT AGTATOGACT CAGTAATTAT AAATAGACCA TTTATAGGAA TTCC 23 34 
( 2 )INFORMATION FOR SEQ ID N015: 
( i )SBQUBJCECHARACI'EHSI'ICS: (A )LENOTl-Itmbasepsirs 
( B )TYPEmck‘macid 
(C )STRANDEDNESSzsiuglc 
(D )TOPOlDGY:|imat 
( '1 i )MOLBCULETYPE:DNA(gmmin) 
( x i )SEQUENCE DExRlP'I'ION: SEQlDNO?: 
TGTGTAGTTG GCCAATCTGG 2O 
( 2 )INTORMATIONFORSBQID NO:6: 
( i )SEQUE‘CECHARACI'EUS'HCS: 
( A )uzNeTm ZOhesepnh-s 
( B )‘I'YP'E: mcldcacid 
(C )STRANDEDNESSningJ: 
( D )IOPOIDGY:Iin=aI 
( i i )MOLKULBTYPEzDNAQemn?c) 
( x i )SBQUENCEDEMRIYI'ION: SEQDNOzG: 
GATTTCCGOT TGGTTCATCG 20 
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We claim: 
1. An oligonucleotide primer pair for use in a PCR-based 
assay for Mycaplasma hyopneumoniae, wherein said pair 
comprises the nucleotide sequence 
5'-AAG'ITCA'I'I‘CGCGCTAGCCC-3' (SEQ ID NOzl) and 
the nucleotide sequence 5‘-GCI‘CCTACTCCK[‘A'ITGCCC 
3' (SEQ ID N02) and wherein said pair hybridizes to 
Mycoplasma hyopneumoniae but does not hybridize to 
Mycoplasma hyorhinis, Mycoplasma ?occulare and Myco 
plasma hyosynoviae. 
Z. A kit for use in detecting the presence of Mycoplasma 
hyopneumoniae DNA in a sample suspected of containing 
said DNA comprising: 
(a) a container; and 
(b) the primer pair of claim 1. in said container. 
3. The kit of claim 2 further comprising a probe compris 
ing the nucleotide sequence 
5‘-GGTAGCCCITCCI'I'I‘GAGGT-3' (SEQ ID NO: 3) that 
hybridizes to an ampli?ed target nucleic acid sequence 
resulting from the use of said primer pair in a polymerase 
chain reaction. 
4. The kit of claim 3 further comprising means for 
detecting the hybridization of said probe to said ampli?ed 
target nucleic acid sequence. 
5. The kit of claim 3 wherein said probe is an oligonucle 
otide consisting of the nucleotide sequence 
5'-GGTAGCCCITCCTI'I‘GAGGT-3' (SEQ ID NO: 3). 
6. A method for detecting the presence of Mycoplasma 
hyopneumoniae in a ?rst sample comprising the steps of: 
(a) isolating the DNA from said Mycoplasma hyopneu 
moniae in said ?rst sample to form a second sample 
containing said isolated DNA; 
(b) amplifying a target nucleic acid sequence in said 
isolated DNA by a polymerase chain which results in 
an ampli?ed target nucleic acid sequence wherein an 
oligonucleotide primer pair used in said reaction com 
prises the nucleotide sequence 
S'AAG'I'I‘CA'ITCGCGCI‘AGCCC-B' (SEQ ID NO: 1) 
and the nucleotide sequence 5‘ 
GCTCCI‘ACI‘CCATA'ITGCCC-T (SEQ ID NO: 2) 
and wherein said pair hybridizes to Mycoplasma hyop 
neumoniae but does not hybridize to Mycoplasma 
hyorhinis, Mycoplasma ?occulare and M ycoplasma 
hyosynoviae; and 
(c) detecting the presence of said ampli?ed target nucleic 
acid sequence in said second sample as a means of 
detecting the presence of Mycoplasma hyopneumoniae 
in said ?rst sample. 
7. The method of claim 6 wherein said target nucleic acid 
sequence comprises nucleotides 810 to 1264 of the sequence 
shown in FIG. 4. 
8. The method of claim 7 wherein said step of isolating 
said DNA comprises disrupting said Mycoplasma hyopneu 
mom'ae and extracting the DNA. 
9. The method of claim 7 wherein said step of amplifying 
said target nucleic acid sequence comprises the steps of: 
(a) heating said second sample in the presence of four 
di?‘erent nucleoside triphosphates and said oligonucle 
otide primer pair for an e?°ective time and at an 
e?‘ective temperature to denature the DNA in said 
second sample. wherein each oligonucleotide primer is 
su?iciently complementary to di?‘erent strands of said 
target nucleic acid sequence to hybridize therewith. 
such that the extension product synthesized from one 
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oligonucleotide primer. when separated from its 
complement. can serve as a template for synthesis of 
the extension product of the other oligonucleotide 
primer; 
(‘0) cooling the denatured DNA to a temperature that 
promotes hybridization of each oligonucleotide primer 
to its complementary strand; 
(c) contacting the natured DNA. at the same time as or 
after step (a) or (b). with a thermostable enzyme that 
catalyzes the combination of the nucleoside triphos 
phates to form primer extension products complemen 
tary to each strand of DNA; 
(d) maintaining the mixture from step (c) at an effective 
temperature for an e?ective time to promote the activ 
ity of the enzyme and to synthesize. for the target 
nucleic acid sequence being detected. an extension 
product of each oligonucleotide primer that is comple 
mentary to each strand of the sequence. but not so high 
as to separate each extension product from its comple 
mentary strand; 
(e) heating the mixture from step (d) for an effective time 
and at an eifective temperature to separate the primer 
extension products from the strands on which they were 
synthesized to produce single-stranded molecules. but 
not so high as to denature the enzyme irreversibly; 
(f) cooling the mixture from step (e) for an elfective time 
and to an effective temperature to promote hybridiza 
tion of each oligonucleotide primer to its complemen 
tary single-stranded molecule produced from step (e); 
and 
(g) maintaining the mixture from step (t) at an effective 
temperature for an effective time to promote the activ 
ity of the enzyme and to synthesize, for the target 
nucleic acid sequence being detected. an extension 
product of each oligonucleotide primer that is comple 
mentary to each strand. but not so high as to separate 
each extension product from its complementary strand. 
resulting in ampli?cation of said target nucleic acid 
sequence if present. wherein steps (f) and (g) are 
carried out simultaneously or sequentially. 
10. The method of claim 9 wherein steps (e). (f). and (g) 
are repeated at least 29 times. 
11. The method of claim 10 wherein said thermostable 
enzyme is a polymerase from Thermus aquaticus. 
12. The method of claim 11 wherein the temperature in 
steps (b) and (t) is from 54° C. to 58° C. 
13. The method of claim 7 wherein said step of detecting 
the presence of said ampli?ed target nucleic acid sequence 
comprises the steps of: 
(a) contacting the ampli?ed target nucleic acid sequence 
with a probe comprising the nucleotide sequence 
5‘-GGTAGCCCI'I‘CCI'ITGAGGT-3‘ (SEQ ID NO: 3) 
which hybridizes to said target nucleic acid sequence; 
and 
(b) determining if hybridization has occurred. 
14. The method of claim 7 wherein said step of detecting 
the presence of said ampli?ed target nucleic acid sequence 
comprises the steps of: 
electrophoresing the ampli?ed target nucleic acid 
sequence in a gel; and 
visualizing the ampli?ed target nucleic acid sequence. 
* * * * * 
